Literature DB >> 12011670

Plasmapheresis and renal replacement therapy in children.

Timothy E Bunchman1.   

Abstract

The use of extracorporeal techniques for the treatment of pediatric diseases has expanded dramatically in the past decade. During this time, experience with both plasmapheresis and renal replacement therapy has become commonplace in ICUs and nephrology programs throughout the world. The indications for these therapies range through treatment of vasculitis, drug removal, support from inborn error metabolism, multiorgan system failure, primary renal disease, and sepsis. Because these therapies are somewhat intermingled based on the commonality of the need for vascular access, extracorporeal blood volumes, and bedside nursing support, and furthermore because the indications for these may overlap, these therapies are often used in tandem or parallel to support the child with illness.

Entities:  

Mesh:

Year:  2002        PMID: 12011670     DOI: 10.1097/00008480-200206000-00005

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  4 in total

1.  Therapeutic plasmapheresis using membrane plasma separation.

Authors:  Aditi Sinha; Anand Narain Tiwari; Rahul Chanchlani; V Seetharamanjaneyulu; Pankaj Hari; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2012-07-06       Impact factor: 1.967

2.  Tandem plasma-exchange and haemodialysis in a paediatric dialysis unit.

Authors:  Fabio Paglialonga; Gianluigi Ardissino; Antonietta Biasuzzi; Sara Testa; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2011-12-02       Impact factor: 3.714

3.  Regional citrate anticoagulation--a safe and effective procedure in pediatric apheresis therapy.

Authors:  Martin Kreuzer; Thurid Ahlenstiel; Nele Kanzelmeyer; Jochen H H Ehrich; Lars Pape
Journal:  Pediatr Nephrol       Date:  2010-10-21       Impact factor: 3.714

Review 4.  Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments.

Authors:  Massimiliano Bertacchi; Paloma Parvex; Jean Villard
Journal:  Clin Transplant       Date:  2022-02-16       Impact factor: 3.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.